BIOGEN INC. PP&E Net 2008-2026 | BIIB
Beta
What is BIOGEN INC.'s current pp&e net?
BIOGEN INC. (BIIB) annual pp&e net for 2025 was $3.06B, a 3.96% decline from 2024. BIOGEN INC. pp&e net for the quarter ending March 31, 2026 was $3.02B.
What was BIOGEN INC.'s pp&e net in 2024?
BIOGEN INC. annual pp&e net for 2024 was $3.18B, a 3.88% decline from 2023.
What was BIOGEN INC.'s pp&e net in 2023?
BIOGEN INC. annual pp&e net for 2023 was $3.31B, a 0.34% increase from 2022.
What is BIOGEN INC.'s 5-year pp&e net CAGR?
BIOGEN INC. pp&e net grew at a compound annual growth rate (CAGR) of 2.18% from FY2020 to FY2025, going from $3.41B to $3.06B over 5 years.
PP&E Net History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Declining
CAGR-2.2%
FY2020
$3.41B
→
FY2025
$3.06B
080910111213141516171819202122232425
5 years selected
PP&E Net History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $3.06B | -4.0% | 10-K |
| FY2024 | $3.18B | -3.9% | 10-K |
| FY2023 | $3.31B | +0.3% | 10-K |
| FY2022 | $3.30B | -3.4% | 10-K |
| FY2021 | $3.42B | +0.1% | 10-K |
| FY2020 | $3.41B | +5.1% | 10-K |
| FY2019 | $3.25B | -9.8% | 10-K |
| FY2018 | $3.60B | +13.2% | 10-K |
| FY2017 | $3.18B | +27.2% | 10-K |
| FY2016 | $2.50B | +14.4% | 10-K |
| FY2015 | $2.19B | +23.9% | 10-K |
| FY2014 | $1.77B | +0.9% | 10-K |
| FY2013 | $1.75B | +0.5% | 10-K |
| FY2012 | $1.74B | +10.9% | 10-K |
| FY2011 | $1.57B | -4.3% | 10-K |
| FY2010 | $1.64B | +0.3% | 10-K |
| FY2009 | $1.64B | +2.7% | 10-K |
| FY2008 | $1.59B | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →